510(k) Report

510(k) · Cleared

Cleared

Lyphochek Diabetes Control

K070546510(k) TraditionalCleared Apr 2, 200735-day reviewClass II21 CFR 864.8625

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Bio-Rad Laboratories · GGM Control, Hemoglobin

Cleared on Apr 2, 2007 as substantially equivalent to K862186 (Bio-Rad, 1986) after a 35-day review. Its family tree reaches back 1 generation to 1986.

Decided
Apr 2, 2007
Review
35 days
Class
Class II
Product code
GGM
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K862186 (1986). No later device cites it as a predicate yet.

K862186 · Lyphochek Glycated Hemoglobin/Whole Blood/Lev.I&II · Bio-Rad · 198619851990199520002005
  1. Root · 1 generation backK862186 Lyphochek Glycated Hemoglobin/Whole Blood/Lev.I&IIBio-Rad · 1986
  2. This deviceK070546 Lyphochek Diabetes ControlBio-Rad Laboratories · 2007
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K862186Lyphochek Glycated Hemoglobin/Whole Blood/Lev.I&IIBio-Rad1986—
0 (this device)K070546Lyphochek Diabetes ControlBio-Rad Laboratories2007—
FIG. 1 — Lineage of K070546, 1986–2007Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GGM? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K862186Lyphochek Glycated Hemoglobin/Whole Blood/Lev.I&II
Summary page 1
…Substantial Equivalence is Claimed Lyphochek Diabetes Control Bio-Rad Laboratories Irvine, California 92618 510 (k) Number: K862186 4.0 Description of Device This is a lyophilized product prepared from human whole blood containing preservati…
Bio-Rad1986—

Also cleared against K862186: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • 1 other device also cites its predicate K862186.

How does its category compare?

All GGM devices

GGM Control, Hemoglobin: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.

FDA decisions per year · GGM

2in 2019

2007: 22019: 2
2007high 2 (2007) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GGM

Too few GGM 510(k)s in any year since 2007 to give a median.

Recalls per year · GGM

2in 2018

2018: 2
2007high 2 (2018) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · GGM

1in 2018

2014: 12018: 1
2007high 1 (2014) · low 0 (2007)2025

MAUDE reports naming product code GGM, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—01
20150—00
20160—00
20170—00
20180—21
20192—00
20200—00
20210—00
20220—00
20230—00
20240—00
20250—00
20260—0—

What is it indicated for?

Lyphochek Diabetes Control is intended for use as an assayed quality control material to monitor the precision of laboratory testing procedures for the analytes listed in the package insert.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K070546: Lyphochek Diabetes Control.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K070546

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026